LYMPHOMA RESEARCH FOUNDATION

Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$42,720,239
Investments
85%
Cash & Equivalents
9%
Receivables (Non-Related)
3%
Other Assets
2%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2025 (Year End)
$8,187,980
Grants Payable
76%
Payables & Accruals
12%
Other Liabilities
10%
Deferred Revenue
2%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$12,523,520
$3,970,789
-68%
Receivables (Non-Related)
$1,451,760
$1,252,855
-14%
Related-Party Receivables
$0
$0
-
Inventories
$0
-
-
Prepaid Expenses
$365,437
$296,095
-19%
Investments
$27,312,260
$36,392,748
+33%
Property, Plant, & Equipment (net)
$33,483
$20,355
-39%
Other Assets
$1,147,579
$787,397
-31%
Total Assets
$42,834,039
$42,720,239
0%
Liabilities
2024
2025
Change
Payables & Accruals
$720,112
$944,372
+31%
Grants Payable
$7,969,260
$6,261,310
-21%
Deferred Revenue
$191,090
$164,393
-14%
Tax-Exempt Bond Liabilities
$0
-
-
Custodial & Escrow Liabilities
$0
-
-
Notes Payable / Debt (Non-Related)
$0
-
-
Related-Party Payables
$0
$0
-
Other Liabilities
$1,192,730
$817,905
-31%
Total Liabilities
$10,073,192
$8,187,980
-19%
Net assets
2024
2025
Change
Restricted Net Assets
$24,767,594
$22,827,797
-8%
Unrestricted Net Assets
$7,993,253
$11,704,462
+46%
Net assets
2024
2025
Change
Net assets
+$32,760,847
+$34,532,259
+5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)